https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-27 / BMC Cancer 2021 May;21(1):625
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-27 / BMC Cancer 2021 May;21(1):6252021-05-27 00:00:002021-05-27 00:00:00Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-21 / Exp Ther Med 2021 Jul;22(1):787
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-21 / Exp Ther Med 2021 Jul;22(1):7872021-05-21 00:00:002023-01-31 15:58:28Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-20 / Cancers (Basel) 2021 May;13(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-20 / Cancers (Basel) 2021 May;13(10)2021-05-20 00:00:002021-05-20 00:00:00Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-19 / Mol Ther Oncolytics 2021 Sep;22:64-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-19 / Mol Ther Oncolytics 2021 Sep;22:64-712021-05-19 00:00:002021-05-19 00:00:00CD133 mRNA-transfected dendritic cells induce coordinated cytotoxic and helper T cell responses against breast cancer stem cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-19 / Vaccines (Basel) 2021 May;9(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-19 / Vaccines (Basel) 2021 May;9(5)2021-05-19 00:00:002021-05-19 00:00:00Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-14 / Ther Apher Dial 2021 Aug;25(4):415-424
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-14 / Ther Apher Dial 2021 Aug;25(4):415-4242021-05-14 00:00:002023-01-31 12:56:12Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-12 / Virol J 2021 May;18(1):98
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-12 / Virol J 2021 May;18(1):982021-05-12 00:00:002021-05-12 00:00:00A bibliometric review of oncolytic virus research as a novel approach for cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-12 / Cancer Med 2021 Jul;10(13):4302-4311
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-12 / Cancer Med 2021 Jul;10(13):4302-43112021-05-12 00:00:002021-08-09 09:14:27Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-10 / Front Oncol 2021;11:672508
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-10 / Front Oncol 2021;11:6725082021-05-10 00:00:002021-05-10 00:00:00Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma
